These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 25983191)
1. Rising to the challenge of multiple Cryptococcus species and the diseases they cause. Idnurm A; Lin X Fungal Genet Biol; 2015 May; 78():1-6. PubMed ID: 25983191 [TBL] [Abstract][Full Text] [Related]
2. Molecules at the interface of Cryptococcus and the host that determine disease susceptibility. Wozniak KL; Olszewski MA; Wormley FL Fungal Genet Biol; 2015 May; 78():87-92. PubMed ID: 25445308 [TBL] [Abstract][Full Text] [Related]
3. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain. Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849 [TBL] [Abstract][Full Text] [Related]
4. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis. Gibson JF; Johnston SA Fungal Genet Biol; 2015 May; 78():76-86. PubMed ID: 25498576 [TBL] [Abstract][Full Text] [Related]
7. A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice. Kwon-Chung KJ; Perfect JR; Levitz SM Mycopathologia; 2012 Jun; 173(5-6):287-93. PubMed ID: 22038679 [TBL] [Abstract][Full Text] [Related]
8. Disseminated Cryptococcus neoformans: case report and review of the literature. Patel NC; Ewanowski C; Kupiec-Banasikowska A; Hogan KP Cutis; 2009 Aug; 84(2):93-6. PubMed ID: 19746767 [TBL] [Abstract][Full Text] [Related]
9. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil. Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969 [TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark. Hagen F; Hare Jensen R; Meis JF; Arendrup MC Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834 [TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India. Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471 [TBL] [Abstract][Full Text] [Related]
13. Ten challenges on Cryptococcus and cryptococcosis. Del Poeta M; Casadevall A Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062 [TBL] [Abstract][Full Text] [Related]
14. Cryptococcal therapies and drug targets: the old, the new and the promising. Coelho C; Casadevall A Cell Microbiol; 2016 Jun; 18(6):792-9. PubMed ID: 26990050 [TBL] [Abstract][Full Text] [Related]